Mood stabilizers, glycogen synthase kinase-3β and cell survival

Molecular Psychiatry

Volumn 7, Issue SUPPL. 1, 2002, Pages

  Jope, R S ^a   Bijur, G N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

catenin; Apoptosis; Bipolar disorder; CREB; Lithium; Neuroprotection

Indexed keywords

LITHIUM;

AFFECTIVE NEUROSIS; ARTICLE; CELL SURVIVAL; DRUG EFFECT; HUMAN; LYMPHOCYTE ACTIVATION; PHOSPHORYLATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTIDEPRESSIVE AGENTS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELL SURVIVAL; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; MODELS, NEUROLOGICAL; MOOD DISORDERS; NEUROPROTECTIVE AGENTS;

EID: 0036214603     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj/mp/4001017     Document Type: Article

References (111)

1. A molecular mechanism for the effect of lithium ondevelopment
2. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
3. Glycogen synthase from rabbit skeletal muscle; effect of insulin on the state of phosphorylation of the seven phosphoserine residues in vivo
4. Lithium and brain signal transduction systems
5. Glycogen synthase kinase-3: Functions in oncogenesis and development
6. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B
7. Inactivation of glycogen synthase kinase-3β by phosphorylation: New kinase connections in insulin and growth-factor signalling
8. Differential regulation of glycogen synthase kinase-3β by protein kinase C isotypes
9. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A
10. Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation
11. Glycogen synthase kinase-3β is a dual specificity kinase differentially regulated by tyrosine and serine/threonine phosphorylation
12. Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase-3β-dependent pathway
13. Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3β and Fyn tyrosine kinase
14. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration
15. Signal transduction by the Wnt family of ligands
16. Binding of GSK-3β to the APC-β-catenin complex and regulation of complex assembly
17. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3
18. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis
19. A GSK-3 binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and β-catenin
20. c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK
21. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73
22. Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity
23. Negative regulation of Jun/AP-1: Conserved function of glycogen synthase kinase 3 and the Drosophila kinase shaggy
24. Glycogen synthase kinase 3 phosphorylates Jun family members in vitro and negatively regulates their transactivating potential in intact cells
25. CREB and memory
26. CREB: A stimulus-induced transcription factor activated by a diverse array of extracellular signals
27. Use of a synthetic peptide as a selective substrate for glycogen synthase kinase 3
28. A secondary phosphorylation of CREB341 at Ser129 is required for the cAMP-mediated control of gene expression. A role for glycogen synthase kinase-3 in the control of gene expression
29. Phosphorylation of the cAMP response element binding protein CREB by cAMP-dependent protein kinase A and glycogen synthase kinase-3 alters DNA-binding affinity, conformation, and increases net charge
30. CREB DNA binding activity is inhibited by glycogen synthase-3β and facilitated by lithium
31. The heat-shock response: Regulation and function of heat-shock proteins and molecular chaperones
32. Repression of the heat shock factor 1 transcriptional activation domain is modulated by constitutive phosphorylation
33. Sequential phosphorylation by mitogen-activated protein kinase and glycogen synthase kinase 3 represses transcriptional activation by heat shock factor-1
34. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3β in the regulation of HSF-1 activity
35. Glycogen synthase kinase 3β negatively regulates both DNA-binding and transcriptional activities of heat shock factor 1
36. Glycogen synthase kinase 3β and extracellular signal-regulated kinase inactivate heat shock transcription factor 1 by facilitating the disappearance of transcriptionally active granules after heat shock
37. A heat shock-responsive domain of human HSF1 that regulates transcription activation domain function
38. Hyperphosphorylation of heat shock transcription factor 1 is correlated with transcriptional competence and slow dissociation of active factor trimers
39. Identification of a putative regulator of early T cell activation genes
40. Glycogen synthase kinase-3β is a negative regulator of cardiomyocyte hypertrophy
41. L-type calcium channels and GSK-3 regulated the activity of NF-ATc4 in hippocampal neurons
42. Direct demonstration of NFATp dephosphorylation and nuclear localization in activated HT-2 cells using a specific NFATp polyclonal antibody
43. Calcineurine binds the transcription factor NFAT1 and reversibly regulates its activity
44. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3
45. Molecular analysis of the c-myc locus in normal tissue and in avian leukosis virus-induced lymphomas
46. Phosphorylation of specific sites in the gag-myc polyproteins encoded by MC29-type viruses correlates with their transforming ability
47. The Myc/Max/Mad network and the transcriptional control of cell behavior
48. Potentiation of growth factor activity by exogenous c-myc expression
49. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max
50. Max: A helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc
51. Sequence-specific DNA binding by the c-Myc protein
52. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression
53. Phosphorylation sites mapping in the N-terminal domain of c-myc modulate its transforming potential
54. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site
55. Site-specific modulation of c-Myc cotransformation by residues phosphorylated in vivo
56. Regulation of c-Myc through phosphorylation at Ser-62 and Ser-71 by c-Jun N-terminal kinase
57. Biological role of the CCAAT/enhancer-binding protein family of transcription factors
58. Fetal adult localization of C/EBP: Evidence for combinational action of transcription factors in cell-specific gene expression
59. 2+ calmodulin kinases activation in hippocampal neurons
60. Insulin regulates transcription of the CCAAT/enhancer binding protein (C/EBP) α, β, and δ genes in fully-differentiated 3T3-L1 adipocytes
61. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein a (C/EBPα) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression
62. Glycogen synthase kinase 3 is an insulin-regulated C/EBPα kinase
63. Nuclear factor-κB/Rel proteins: A point of convergence of signalling pathways relevant in neuronal function and dysfunction
64. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation
65. Wnt-1 dependent activation of the survival factor NF-κB in PC12 cells
66. Tau protein kinase I is essential for amyloid β-protein-induced neurotoxicity
67. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway
68. Glycogen synthase kinase-3β facilitates staurosporine-and heat shock-induced apoptosis. Protection by lithium
69. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal
70. Glycogen synthase kinase-3β activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal
71. HIV-1 Tat-mediated activation of glycogen synthase kinase-3β contributes to Tat-mediated neurotoxicity
72. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau
73. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase
74. Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3β in brain
75. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3
76. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons
77. Lithium reduces tau phosphorylation: Effects in living cells and in neurons at therapeutic concentrations
78. The interrelationship between selective tau phosphorylation and microtubule association
79. Tau protein in normal and Alzheimer's disease brain: An update
80. Specificity and mechanism of action of some commonly used protein kinase inhibitors
81. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
82. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium
83. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
84. A cell-free assay system for β-catenin signaling that recapitulates direct inductive events in the early xenopus laevis embryo
85. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
86. AP-1 and NF-κB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium
87. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain
88. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells
89. Lithium stimulates gene expression through the AP-1 transcription factor pathway
90. Anti-bipolar therapy: Mechanism of action of lithium
91. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells
92. Lithium chloride promotes short-term survival of PC12 cells after serum and NGF deprivation
93. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons
94. Lithium protects against ouabain-induced cell death
95. LiCI promotes survival of GABAergic neurons from cerebellum and cerebral cortex: LiCI induces survival of GABAergic neurons
96. Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum
97. + protection of cerebellar granule neurons switched to non-depolarizing medium
98. Partial lithium-associated protection against apoptosis induced by C2-ceramide in cerebellar granule neurons
99. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx
100. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine
101. Lithium protects cultured neurons against β-amyloid-induced neurodegeneration
102. +
103. +
104. A novel evidence of different mechanisms of lithium and valproate neuroprotective action on human SY5Y neuroblastoma cells: Caspase-3 dependency
105. β-amyloid peptide-induced death of PC12 cells and cerebellar granule cell neurons is inhibited of long-term lithium treatment
106. + in cerebellar granule cells
107. A protective effect of lithium on rat behaviour altered by ibotenic acid lesions of the basal forebrain cholinergic system
108. Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats
109. Synergistic effects of tetrahydroaminoacridine and lithium on cholinergic function after excitotoxic basal forebrain lesions in rat
110. Lithium treatment in ovo: Effects on embryonic heart rate, natural death of ciliary ganglion neurons, and brain expression of a highly conserved chicken homolog of human MTG8/ETO
111. Glycogen synthase kinase-3β mood stabilizers, and neuroprotection